Skip to content

Modelling study predicts efficacy and cost-effectiveness of HIV treatment after single-dose nevirapine

Malnourishment at time HIV treatment is started equals much poorer survival

Mortality and causes of death amongst people taking HIV treatment in Senegal examined

AZT/3TC/tenofovir regimen effective first-line therapy in resource-limited settings

Grey nails help predict need to start anti-HIV therapy in Malawians

Tipranavir study halted in treatment-naive

Genetic testing can predict who is at risk of abacavir hypersensitivity

Should patients with high viral loads and high CD4 cell counts start anti-HIV therapy? (corrected)

Twice-daily boosted fosamprenavir non-inferior to twice-daily Kaletra in treatment-naive